| Dr Karen T Dorn, MD | |
|
1805 Wisconsin Ave, Benson, MN 56215 | |
| (320) 843-2030 | |
| (320) 314-1542 |
| Full Name | Dr Karen T Dorn |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 26 Years |
| Location | 1805 Wisconsin Ave, Benson, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710953443 | NPI | - | NPPES |
| 087744100 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 43134 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fairview Ridges Hospital | Burnsville, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Health Services | 1951213057 | 559 |
News Archive
Medtronic, Inc., today reported the initiation and first enrollments of patients in COPE-HCV (COntinuous Interferon Delivery via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV), the company's first-ever clinical study using an external pump infusion system to treat patients with the hepatitis C virus (HCV).
Researchers from McGill University's Rosalind and Morris Goodman Cancer Research Centre, the Research Institute of the McGill University Health Centre, the Dana-Farber Cancer Institute and Harvard Medical School have discovered a gene signature that can accurately predict which breast cancer patients are at risk of relapse, thereby sparing those who are not from the burdens associated with unnecessary treatment.
Bacteria and other microorganisms display structures from sugar molecules on their surfaces. These sugar structures play an important role for immune defense.
The Institute for Research on Well-being Policies (Poliwelfare) of the University of Valencia, a partner of European project Mind Inclusion 2.0, has developed the app Mind Inclusion 2.0, to promote the inclusion of people with disability in public places. The app is already available in the Google Play Store in five languages.
Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life, in comparison to the standard surgery.
› Verified 6 days ago
| Entity Name | Fairview Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
Medtronic, Inc., today reported the initiation and first enrollments of patients in COPE-HCV (COntinuous Interferon Delivery via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV), the company's first-ever clinical study using an external pump infusion system to treat patients with the hepatitis C virus (HCV).
Researchers from McGill University's Rosalind and Morris Goodman Cancer Research Centre, the Research Institute of the McGill University Health Centre, the Dana-Farber Cancer Institute and Harvard Medical School have discovered a gene signature that can accurately predict which breast cancer patients are at risk of relapse, thereby sparing those who are not from the burdens associated with unnecessary treatment.
Bacteria and other microorganisms display structures from sugar molecules on their surfaces. These sugar structures play an important role for immune defense.
The Institute for Research on Well-being Policies (Poliwelfare) of the University of Valencia, a partner of European project Mind Inclusion 2.0, has developed the app Mind Inclusion 2.0, to promote the inclusion of people with disability in public places. The app is already available in the Google Play Store in five languages.
Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life, in comparison to the standard surgery.
› Verified 6 days ago
| Entity Name | Fairview Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346432218 PECOS PAC ID: 7113830142 Enrollment ID: O20031106000516 |
News Archive
Medtronic, Inc., today reported the initiation and first enrollments of patients in COPE-HCV (COntinuous Interferon Delivery via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV), the company's first-ever clinical study using an external pump infusion system to treat patients with the hepatitis C virus (HCV).
Researchers from McGill University's Rosalind and Morris Goodman Cancer Research Centre, the Research Institute of the McGill University Health Centre, the Dana-Farber Cancer Institute and Harvard Medical School have discovered a gene signature that can accurately predict which breast cancer patients are at risk of relapse, thereby sparing those who are not from the burdens associated with unnecessary treatment.
Bacteria and other microorganisms display structures from sugar molecules on their surfaces. These sugar structures play an important role for immune defense.
The Institute for Research on Well-being Policies (Poliwelfare) of the University of Valencia, a partner of European project Mind Inclusion 2.0, has developed the app Mind Inclusion 2.0, to promote the inclusion of people with disability in public places. The app is already available in the Google Play Store in five languages.
Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life, in comparison to the standard surgery.
› Verified 6 days ago
| Entity Name | Healtheast Woodwinds Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356309322 PECOS PAC ID: 9638082563 Enrollment ID: O20031107000110 |
News Archive
Medtronic, Inc., today reported the initiation and first enrollments of patients in COPE-HCV (COntinuous Interferon Delivery via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV), the company's first-ever clinical study using an external pump infusion system to treat patients with the hepatitis C virus (HCV).
Researchers from McGill University's Rosalind and Morris Goodman Cancer Research Centre, the Research Institute of the McGill University Health Centre, the Dana-Farber Cancer Institute and Harvard Medical School have discovered a gene signature that can accurately predict which breast cancer patients are at risk of relapse, thereby sparing those who are not from the burdens associated with unnecessary treatment.
Bacteria and other microorganisms display structures from sugar molecules on their surfaces. These sugar structures play an important role for immune defense.
The Institute for Research on Well-being Policies (Poliwelfare) of the University of Valencia, a partner of European project Mind Inclusion 2.0, has developed the app Mind Inclusion 2.0, to promote the inclusion of people with disability in public places. The app is already available in the Google Play Store in five languages.
Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life, in comparison to the standard surgery.
› Verified 6 days ago
| Entity Name | Healtheast Medical Research Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639125503 PECOS PAC ID: 3971407636 Enrollment ID: O20031124000507 |
News Archive
Medtronic, Inc., today reported the initiation and first enrollments of patients in COPE-HCV (COntinuous Interferon Delivery via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV), the company's first-ever clinical study using an external pump infusion system to treat patients with the hepatitis C virus (HCV).
Researchers from McGill University's Rosalind and Morris Goodman Cancer Research Centre, the Research Institute of the McGill University Health Centre, the Dana-Farber Cancer Institute and Harvard Medical School have discovered a gene signature that can accurately predict which breast cancer patients are at risk of relapse, thereby sparing those who are not from the burdens associated with unnecessary treatment.
Bacteria and other microorganisms display structures from sugar molecules on their surfaces. These sugar structures play an important role for immune defense.
The Institute for Research on Well-being Policies (Poliwelfare) of the University of Valencia, a partner of European project Mind Inclusion 2.0, has developed the app Mind Inclusion 2.0, to promote the inclusion of people with disability in public places. The app is already available in the Google Play Store in five languages.
Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life, in comparison to the standard surgery.
› Verified 6 days ago
| Entity Name | Healtheast St Joseph's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134186273 PECOS PAC ID: 2365348869 Enrollment ID: O20031208000245 |
News Archive
Medtronic, Inc., today reported the initiation and first enrollments of patients in COPE-HCV (COntinuous Interferon Delivery via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV), the company's first-ever clinical study using an external pump infusion system to treat patients with the hepatitis C virus (HCV).
Researchers from McGill University's Rosalind and Morris Goodman Cancer Research Centre, the Research Institute of the McGill University Health Centre, the Dana-Farber Cancer Institute and Harvard Medical School have discovered a gene signature that can accurately predict which breast cancer patients are at risk of relapse, thereby sparing those who are not from the burdens associated with unnecessary treatment.
Bacteria and other microorganisms display structures from sugar molecules on their surfaces. These sugar structures play an important role for immune defense.
The Institute for Research on Well-being Policies (Poliwelfare) of the University of Valencia, a partner of European project Mind Inclusion 2.0, has developed the app Mind Inclusion 2.0, to promote the inclusion of people with disability in public places. The app is already available in the Google Play Store in five languages.
Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life, in comparison to the standard surgery.
› Verified 6 days ago
| Entity Name | Healtheast St John's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447218482 PECOS PAC ID: 9234035742 Enrollment ID: O20031208000320 |
News Archive
Medtronic, Inc., today reported the initiation and first enrollments of patients in COPE-HCV (COntinuous Interferon Delivery via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV), the company's first-ever clinical study using an external pump infusion system to treat patients with the hepatitis C virus (HCV).
Researchers from McGill University's Rosalind and Morris Goodman Cancer Research Centre, the Research Institute of the McGill University Health Centre, the Dana-Farber Cancer Institute and Harvard Medical School have discovered a gene signature that can accurately predict which breast cancer patients are at risk of relapse, thereby sparing those who are not from the burdens associated with unnecessary treatment.
Bacteria and other microorganisms display structures from sugar molecules on their surfaces. These sugar structures play an important role for immune defense.
The Institute for Research on Well-being Policies (Poliwelfare) of the University of Valencia, a partner of European project Mind Inclusion 2.0, has developed the app Mind Inclusion 2.0, to promote the inclusion of people with disability in public places. The app is already available in the Google Play Store in five languages.
Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life, in comparison to the standard surgery.
› Verified 6 days ago
| Entity Name | Healtheast Care System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194787465 PECOS PAC ID: 7214833763 Enrollment ID: O20031208000483 |
News Archive
Medtronic, Inc., today reported the initiation and first enrollments of patients in COPE-HCV (COntinuous Interferon Delivery via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV), the company's first-ever clinical study using an external pump infusion system to treat patients with the hepatitis C virus (HCV).
Researchers from McGill University's Rosalind and Morris Goodman Cancer Research Centre, the Research Institute of the McGill University Health Centre, the Dana-Farber Cancer Institute and Harvard Medical School have discovered a gene signature that can accurately predict which breast cancer patients are at risk of relapse, thereby sparing those who are not from the burdens associated with unnecessary treatment.
Bacteria and other microorganisms display structures from sugar molecules on their surfaces. These sugar structures play an important role for immune defense.
The Institute for Research on Well-being Policies (Poliwelfare) of the University of Valencia, a partner of European project Mind Inclusion 2.0, has developed the app Mind Inclusion 2.0, to promote the inclusion of people with disability in public places. The app is already available in the Google Play Store in five languages.
Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life, in comparison to the standard surgery.
› Verified 6 days ago
| Entity Name | Fairview Express Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
Medtronic, Inc., today reported the initiation and first enrollments of patients in COPE-HCV (COntinuous Interferon Delivery via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV), the company's first-ever clinical study using an external pump infusion system to treat patients with the hepatitis C virus (HCV).
Researchers from McGill University's Rosalind and Morris Goodman Cancer Research Centre, the Research Institute of the McGill University Health Centre, the Dana-Farber Cancer Institute and Harvard Medical School have discovered a gene signature that can accurately predict which breast cancer patients are at risk of relapse, thereby sparing those who are not from the burdens associated with unnecessary treatment.
Bacteria and other microorganisms display structures from sugar molecules on their surfaces. These sugar structures play an important role for immune defense.
The Institute for Research on Well-being Policies (Poliwelfare) of the University of Valencia, a partner of European project Mind Inclusion 2.0, has developed the app Mind Inclusion 2.0, to promote the inclusion of people with disability in public places. The app is already available in the Google Play Store in five languages.
Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life, in comparison to the standard surgery.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karen T Dorn, MD 1805 Wisconsin Ave, Benson, MN 56215 Ph: (320) 843-2030 | Dr Karen T Dorn, MD 1805 Wisconsin Ave, Benson, MN 56215 Ph: (320) 843-2030 |
News Archive
Medtronic, Inc., today reported the initiation and first enrollments of patients in COPE-HCV (COntinuous Interferon Delivery via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV), the company's first-ever clinical study using an external pump infusion system to treat patients with the hepatitis C virus (HCV).
Researchers from McGill University's Rosalind and Morris Goodman Cancer Research Centre, the Research Institute of the McGill University Health Centre, the Dana-Farber Cancer Institute and Harvard Medical School have discovered a gene signature that can accurately predict which breast cancer patients are at risk of relapse, thereby sparing those who are not from the burdens associated with unnecessary treatment.
Bacteria and other microorganisms display structures from sugar molecules on their surfaces. These sugar structures play an important role for immune defense.
The Institute for Research on Well-being Policies (Poliwelfare) of the University of Valencia, a partner of European project Mind Inclusion 2.0, has developed the app Mind Inclusion 2.0, to promote the inclusion of people with disability in public places. The app is already available in the Google Play Store in five languages.
Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life, in comparison to the standard surgery.
› Verified 6 days ago